Results 91 to 100 of about 1,194 (166)

Misuse of CNS drugs [PDF]

, 2003
Koponen-Piironen, Hanna-Maija, Pennanen, Pirjo   +1 more
core   +1 more source

Association Between HLA-B5801 Positivity and Patient Characteristics and Clinical Outcomes in Gout. [PDF]

In Vivo
Ahn SS, Kim JA, Bae K.
europepmc   +1 more source

The treatment of gout [PDF]

, 2003
Yli-Kerttula, Timo
core   +1 more source

Research progress on multidimensional intervention strategies for hyperuricemia: Western medicine, Traditional Chinese Medicine, and emerging therapies. [PDF]

Front Endocrinol (Lausanne)
Li X, Chen Z, Zhang Y, Fan C, Chen L, Xu X, Chang J, Qiang W, Jiang H, Liu C.   +9 more
europepmc   +1 more source

National Agency for Medicines' 10th anniversary / [PDF]

, 2003
Fellman-Paul, Liisa, Wahlroos, Hannes
core   +1 more source

The Influence of Patient Factors on the Population Pharmacokinetics of Colchicine: Implications for Safe and Effective Dosing. [PDF]

Clin Pharmacokinet
Wright DFB, Hishe HZ, Dalbeth N, Horne A, Drake J, Haslett J, Stamp LK.   +6 more
europepmc   +1 more source

Roles of traditional Chinese medicine extracts in hyperuricemia and gout treatment: Mechanisms and clinical applications. [PDF]

World J Gastroenterol
Wang YB, Jin CZ.
europepmc   +1 more source

Gouty tophi of the pinna. [PDF]

BMJ Case Rep
Gurney M, Morris S, Saw K.
europepmc   +1 more source

Diabetes Mellitus [PDF]

, 1998
Barendse, S, Bradley, Clare, Hendrieckx, C, Pierce , MB, Riazi, Afsane   +4 more
core  

Comparison of pharmacokinetic and pharmacodynamic properties of allopurinol and benzbromarone in a quail model of hyperuricemia. [PDF]

J Vet Sci
Zheng S, Bu Y, Li S, Chen N.
europepmc   +1 more source